• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXL01F73 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2001-12-07 广东药学院 Guangdong Pharmaceutical University Approval Completed-Pending Certificated 2003-04-07 view
CYHS1400490 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(6) Generic Drug 2014-06-25 重庆圣华曦药业股份有限公司 Chongqing Shenghuaxi Pharmaceutical Ltd In Review 2014-06-24 view
CXL01G53 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2002-02-26 山东医科大学医药保健科技开发公司 Shandong Shanda Medical Science and Technology Research Center Certificate Issued 2003-08-01 view
CXL00526 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2001-01-18 合肥兆峰科大药业有限公司 Zhaoke Pharmaceutical (Hefei) Co Ltd Certificate Issued 2002-04-30 view
CXL01352 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2001-05-18 保定步长天浩制药有限公司 Baoding Buchang Tianhao Pharmaceutical Co Ltd Approval Completed-Pending Certificated 2003-03-20 view
X0404514 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs New Drug Application 2004-08-16 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd Certificate Issued 2005-05-27 view
CXL01853 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2002-03-08 沈阳中海生物技术开发有限公司 Shenyang Zhonghai Biological Technology Development Co Ltd Certificate Issued 2004-10-10 view
JTH1800435 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs Disposable Import Drug Application 2019-01-04 AUROBINDO PHARMA LIMITED Aurobindo Pharma Ltd Certificate Issued 2019-01-22 view
CXL01H30 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2003-10-24 北京深文科技开发有限责任公司 Beijing Shenwen Medical Technology Development Co Ltd Certificate Issued 2003-12-15 view
CXL00437 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2002-01-16 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2004-11-08 view
CXL01022 盐酸雷洛昔芬 raloxifene hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2001-07-06 海南新世通药物研究所 Hainan XinShiTong Pharmaceutical Research Institute Certificate Issued 2004-10-10 view
CXHL0501708 盐酸雷洛昔芬分散片 raloxifene hydrochloride Tablet Chemical Drugs(5) New Drug Application 2005-10-26 东盛科技股份有限公司西安制药厂 Topsun Science & Technology Co Ltd Certificate Issued 2006-08-07 view
CYHB2201904 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs Supplementary Application 2022-10-15 Jiangsu Hengrui Pharmaceuticals Co Ltd view
JXHL1300122 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs Import Drug Application 2013-05-08 韩美药品株式会社 Hanmi Pharm Co Ltd Certificate Issued 2015-12-03 view
JYHZ1700055 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs License Renew 2017-08-03 Eli Lilly Nederland B.V Eli Lilly Nederland BV Certificate Issued 2017-09-26 view
CXL01H31 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs(2) New Drug Application 2003-06-18 北京深文科技开发有限责任公司 Beijing Shenwen Medical Technology Development Co Ltd Certificate Issued 2004-09-24 view
JYHB2000792 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-10 Eli Lilly Nederland B.V Eli Lilly Nederland BV Filed 2020-06-16 view
JYHB0800214 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs Supplementary Application 2008-04-11 Eli Lilly Nederland B.V Eli Lilly Nederland BV Certificate Issued 2008-10-10 view
CXL01023 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs(2) New Drug Application 2001-07-06 海南新世通药物研究所 Hainan XinShiTong Pharmaceutical Research Institute Certificate Issued 2004-10-10 view
JYHB1801234 盐酸雷洛昔芬片 raloxifene hydrochloride Tablet Chemical Drugs Supplementary Application 2018-10-15 Eli Lilly Nederland B.V Eli Lilly Nederland BV Filed 2018-10-22 view